Skip to main content

Editorial Board

Professor Rodney Hicks, MBBS(Hons), MD, St Vincent’s Hospital, University of Melbourne; and Alfred Hospital, Monash University, Australia
Professor Annick Van den Abbeele, MD, Dana-Farber Cancer Institute, USA

Section Editors

Artificial intelligence, machine learning and radiomics
Professor Fred Prior, PhD, University of Arkansas for Medical Sciences, USA

Breast imaging
Dr Nuala Healy, MD, Cambridge University Hospitals NHS Foundation Trust, UK
Dr Sarah Vinnicombe, MBBS, Ninewells Hospital Medical School, UK

Chest imaging
Professor Hiroto Hatabu, MD, PhD, Brigham and Women's Hospital and Harvard Medical School, USA
Professor Dr. Matthijs Oudkerk, MD, University of Groningen, the Netherlands

Colorectal cancer
Professor Massimo Bellomi, MD, European Institute of Oncology, Italy

Endocrine malignancy
Dr Jean-Mathieu Beauregard, MD, Laval University, Canada

Genitourinary and evidence-based medicine
Dr Katherine Krajewski, MD, Dana-Farber Cancer Institute, USA

Gynecologic oncology
Dr Nishat Bharwani, MBBS, Imperial College Healthcare NHS Trust, UK
Professor Anju Sahdev, MBBS, Saint Bartholomew's Hospital, UK

Hepatobiliary and upper gastrointestinal imaging
Dr Akshay Baheti, MD, Tata Memorial Centre, India
Asst. Prof Kyung Won Kim, MD, PhD, Asan Medical Center, South Korea
Dr Saugata Sen, MD, Tata Medical Center, Kolkata, India
Musculoskeletal Imaging
Assoc. Prof. Stephen Schlicht, MBBS, Peter MacCallum Cancer Centre, Australia
Dr James Hallinan, MBChB, National University of Singapore, Singapore

Dr Raymond Huang, MD, PhD, Brigham and Women’s Hospital, USA
Dr Behroze Adi Vachha, MD, PhD, UMass Chan Medical School, USA

Nuclear medicine
Professor Michael Hofman, MBBS, Peter MacCallum Cancer Centre, Australia

Pediatric neuroimaging
Professor Thierry Huisman, MD, Johns Hopkins Hospital, USA

Pediatric cancer imaging (radiology)
Professor Derek Roebuck, MBBS, Great Ormond Street Hospital, UK

Pediatric cancer imaging (molecular imaging)
Dr Stephan D. Voss, MD, PHD, Boston Children’s Hospital, USA

Professor Markus Schwaiger, MD, Technical University of Munich, Germany

Prostate cancer
Assoc. Prof Fiona M. Fennessy, MD, PhD, Brigham and Women’s Hospital/Dana-Farber Cancer Institute, USA

Professor Ken Herrmann, MD, University Hospital Essen, Germany
Dr Amir Iravani, MD, University of Washington, USA

Thoracic oncology
Prof Hiroto Hatabu, Brigham and Women's Hospital and Harvard Medical School, USA

Tumor characterization
Professor Clemens Cyran, MD, Ludwig-Maximilian-University of Munich, Germany

Editorial Board
Professor Nicolas Aide, MD, PhD, Caen University Hospital, France
Dr Alexandra  Athanasiou, MD, Mitera Hospital, Greece
Dr Ravikanth Balaji, MBBS, Apollo Speciality Hospital, India
Professor Francois Benard, MD, British Columbia Cancer Agency, Canada
Professor Sotirios Bisdas, MD, PhD, University College London, UK
Professor Abdul Jalil Nordin, MD, Universiti Putra Malaysia, Malaysia
Prof Jeong Min Lee, MD, PhD, Seoul National University Hospital, South Korea
Dr Marius E. Mayerhoefer, MD, PhD, Memorial Sloan Kettering Cancer Center, USA
Dr Srinivasan Mukundan, Jr., MD, PhD, Harvard Medical School, USA
Dr Clair Shadbolt, MD, The Peter MacCallum Cancer Centre, Australia
Dr Eric Turcotte, MD, Sherbrooke Molecular Imaging Center, Canada
Dr Hebert Alberto Vargas, MD, Memorial Sloan Kettering Cancer Center, USA

Official journal of

Annual Journal Metrics

  • 2022 Citation Impact
    4.9 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.636 - SNIP (Source Normalized Impact per Paper)
    1.231 - SJR (SCImago Journal Rank)

    2022 Speed
    14 days submission to first editorial decision for all manuscripts (Median)
    122 days submission to accept (Median)

    2022 Usage 
    454 Altmetric mentions 

Download journal leaflet